119 related articles for article (PubMed ID: 15530662)
21. Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains.
Beilin O; Karussis DM; Korczyn AD; Gurwitz D; Aronovich R; Mizrachi-Kol R; Chapman J
Neuroreport; 2007 Apr; 18(6):581-4. PubMed ID: 17413661
[TBL] [Abstract][Full Text] [Related]
22. APP processing and the APP-KPI domain involvement in the amyloid cascade.
Menéndez-González M; Pérez-Pinera P; Martínez-Rivera M; Calatayud MT; Blázquez Menes B
Neurodegener Dis; 2005; 2(6):277-83. PubMed ID: 16909010
[TBL] [Abstract][Full Text] [Related]
23. Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology.
Saldaña M; Pujols L; ; Roca-Ferrer J; Cardozo A; Aguilar E; Bonastre M; Marin C
Mov Disord; 2008 Apr; 23(6):804-10. PubMed ID: 18307244
[TBL] [Abstract][Full Text] [Related]
24. Contribution of Kunitz protease inhibitor and transmembrane domains to amyloid precursor protein homodimerization.
Ben Khalifa N; Tyteca D; Courtoy PJ; Renauld JC; Constantinescu SN; Octave JN; Kienlen-Campard P
Neurodegener Dis; 2012; 10(1-4):92-5. PubMed ID: 22343802
[TBL] [Abstract][Full Text] [Related]
25. Serine proteinase inhibitors in human skeletal muscle: expression of beta-amyloid protein precursor and alpha 1-antichymotrypsin in vivo and during myogenesis in vitro.
Akaaboune M; Verdière-Sahuqué M; Lachkar S; Festoff BW; Hantaï D
J Cell Physiol; 1995 Dec; 165(3):503-11. PubMed ID: 7593229
[TBL] [Abstract][Full Text] [Related]
26. Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain.
Willoughby DA; Rozovsky I; Lo AC; Finch CE
J Mol Neurosci; 1995; 6(4):257-76. PubMed ID: 8860237
[TBL] [Abstract][Full Text] [Related]
27. Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex.
Kim HS; Lee SH; Kim SS; Kim YK; Jeong SJ; Ma J; Han DH; Cho BK; Suh YH
Neuroreport; 1998 Feb; 9(3):533-7. PubMed ID: 9512402
[TBL] [Abstract][Full Text] [Related]
28. Glial conditioned medium alters the expression of amyloid precursor protein in SH-SY5Y neuroblastoma cells.
Hirose Y; Imai Y; Nakajima K; Takemoto N; Toya S; Kohsaka S
Biochem Biophys Res Commun; 1994 Jan; 198(2):504-9. PubMed ID: 8297361
[TBL] [Abstract][Full Text] [Related]
29. High level of amyloid precursor protein expression in neurite-promoting olfactory ensheathing glia (OEG) and OEG-derived cell lines.
Moreno-Flores MT; Lim F; Martín-Bermejo MJ; Díaz-Nido J; Avila J; Wandosell F
J Neurosci Res; 2003 Mar; 71(6):871-81. PubMed ID: 12605414
[TBL] [Abstract][Full Text] [Related]
30. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies.
Saldaña M; Mullol J; Aguilar E; Bonastre M; Marin C
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):308-16. PubMed ID: 17442064
[TBL] [Abstract][Full Text] [Related]
32. Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluid.
Van Setten GB; Nilsson L; Hahne S; Johnston JA; Kvanta A; Gandy SE; Näslund J; Nordstedt C
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2585-93. PubMed ID: 8977472
[TBL] [Abstract][Full Text] [Related]
33. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
[TBL] [Abstract][Full Text] [Related]
35. Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease.
Jin JK; Ahn BH; Na YJ; Kim JI; Kim YS; Choi EK; Ko YG; Chung KC; Kozlowski PB; Min do S
Neurobiol Aging; 2007 Jul; 28(7):1015-27. PubMed ID: 16797788
[TBL] [Abstract][Full Text] [Related]
36. Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
Bombois S; Maurage CA; Gompel M; Deramecourt V; Mackowiak-Cordoliani MA; Black RS; Lavielle R; Delacourte A; Pasquier F
Arch Neurol; 2007 Apr; 64(4):583-7. PubMed ID: 17420322
[TBL] [Abstract][Full Text] [Related]
37. Structural features of the KPI domain control APP dimerization, trafficking, and processing.
Ben Khalifa N; Tyteca D; Marinangeli C; Depuydt M; Collet JF; Courtoy PJ; Renauld JC; Constantinescu S; Octave JN; Kienlen-Campard P
FASEB J; 2012 Feb; 26(2):855-67. PubMed ID: 22085646
[TBL] [Abstract][Full Text] [Related]
38. How to diagnose dementia with Lewy bodies: state of the art.
Geser F; Wenning GK; Poewe W; McKeith I
Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
[TBL] [Abstract][Full Text] [Related]
39. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.
Boström F; Jönsson L; Minthon L; Londos E
Alzheimer Dis Assoc Disord; 2007; 21(2):150-4. PubMed ID: 17545741
[TBL] [Abstract][Full Text] [Related]
40. Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer's disease.
Kai T; Asai Y; Sakuma K; Koeda T; Nakashima K
J Neurol Sci; 2005 Oct; 237(1-2):89-95. PubMed ID: 16019033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
